B
TMDX icon

Bailard’s Transmedics TMDX Stock Holding History

Bailard’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,700
Closed -$227K – 772
2023
Q2 		$227K Buy
+2,700
New +$207K 0.01% 601

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Bailard's TMDX Position: Q3 2023 in Review

Bailard sold out of Transmedics (TMDX) in Q3 2023, closing a stake of 2,700 shares — an estimated $227K sold.

Bailard first reported a position in TMDX in Q2 2023 and held it in 1 quarter. The position peaked at $227K in Q2 2023. 221 funds tracked by Wall St. Rank hold TMDX as of Q3 2023.

  • Bailard reported no remaining Transmedics position as of Q3 2023 after selling out during the quarter.
  • Bailard sold 2,700 Transmedics shares in Q3 2023, an estimated $227K.
  • Bailard first reported a position in Transmedics in Q2 2023 and held it in 1 quarter.
  • Bailard's Transmedics position peaked at $227K in Q2 2023.
  • 221 funds tracked by Wall St. Rank held Transmedics as of Q3 2023.

Based on Bailard's 13F filing for Q3 2023, filed 24 Oct 2023.